Better Sleep Study

a study on Depression Delayed Sleep Phase

Summary

Eligibility
for people ages 12-18 (full criteria)
Location
at San Francisco, California
Dates
study started
completion around

Description

Summary

The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depression and a misaligned relationship between biological circadian timing and waketime utilizing a cognitive-behavioral sleep intervention.

Official Title

A Confirmatory Efficacy Trial of Engaging a Novel Sleep/Circadian Rhythm Target as Treatment for Depression in Adolescents

Keywords

Depression in Adolescence, Delayed Sleep Phase, Depression, Adolescents, Sleep, Intervention, Depressive Disorder, TranS-C, Psychoeducation

Eligibility

For people ages 12-18

Inclusion Criteria:

Exclusion Criteria:

  • mental health/behavioral symptoms that would preclude productive engagement in study assessments or intervention (e.g., active psychosis; Bipolar Disorder; drug dependence
  • severe or unstable medical or psychiatric condition such that treatment has changed within the last month or is expected to change during the course of the study or that would preclude ability to adhere to study procedures (e.g. terminal end-stage cancer)
  • current use of medications or herbs with known effects on sleep
  • plan to undergo or have had medication change in the last 8 weeks

Location

  • UCSF Nancy Friend Pritzker Psychiatry Building accepting new patients
    San Francisco California 94107 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06139861
Study Type
Interventional
Participants
Expecting 200 study participants
Last Updated
Contact us about this trial